Wells Fargo
RVLP

Wells Fargo’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Wells Fargo’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,246
Closed -$1.32K – 7824
2023
Q3 		$1.32K Buy
15,246
+10
+0.1% +$3 ﹤0.01% 6155
2023
Q2 		$8.53K Buy
15,236
+10
+0.1% +$9 ﹤0.01% 5944
2023
Q1 		$17.4K Sell
15,226
-1,497
-9% -$1.8K ﹤0.01% 5690
2022
Q4 		$18.7K Sell
16,723
-6,994
-29% -$11.1K ﹤0.01% 5289
2022
Q3 		$49K Sell
23,717
-157
-0.7% -$305 ﹤0.01% 4976
2022
Q2 		$32K Buy
23,874
+23
+0.1% +$33 ﹤0.01% 5240
2022
Q1 		$40K Buy
23,851
+101
+0.4% +$144 ﹤0.01% 5758
2021
Q4 		$25K Buy
23,750
+6,740
+40% +$10.9K ﹤0.01% 6261
2021
Q3 		$50K Buy
17,010
+10,000
+143% +$33.6K ﹤0.01% 5632
2021
Q2 		$21K Sell
7,010
-8,923
-56% -$27.3K ﹤0.01% 5885
2021
Q1 		$52K Sell
15,933
-1,404
-8% -$5.78K ﹤0.01% 5800
2020
Q4 		$71K Sell
17,337
-10,372
-37% -$59.8K ﹤0.01% 5477
2020
Q3 		$150K Buy
27,709
+16,781
+154% +$96.7K ﹤0.01% 5100
2020
Q2 		$74K Sell
10,928
-445
-4% -$2.18K ﹤0.01% 5355
2020
Q1 		$36K Buy
11,373
+6,722
+145% +$35.8K ﹤0.01% 5449
2019
Q4 		$32K Sell
4,651
-1
-0% -$5 ﹤0.01% 5636
2019
Q3 		$18K Buy
4,652
+232
+5% +$786 ﹤0.01% 5833
2019
Q2 		$17K Buy
4,420
+403
+10% +$1.34K ﹤0.01% 5821
2019
Q1 		$14K Buy
+4,017
New +$29.6K ﹤0.01% 5596

Other funds holding RVLP

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Wells Fargo's RVLP Position: Q4 2023 in Review

Wells Fargo sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 15,246 shares — an estimated $1.32K sold.

Wells Fargo first reported a position in RVLP in Q1 2019 and held it in 19 quarters. The position peaked at $150K in Q3 2020. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

  • Wells Fargo reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Wells Fargo sold 15,246 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $1.32K.
  • Wells Fargo first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2019 and held it in 19 quarters.
  • Wells Fargo's RVL Pharmaceuticals plc Ordinary Shares position peaked at $150K in Q3 2020.
  • 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.